Lv2
124 积分 2024-02-22 加入
Generation of Chimeric Antigen Receptor T Cells Using Gammaretroviral Vectors
23天前
已完结
CARMA-1: The phase I Study of SENL101, a naturally selected nanobody based CD7 CAR-T therapy, in relapsed or refractory T-ALL/lbl
1个月前
已关闭
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies
1个月前
已关闭
Universal base-edited CAR7 T cells for T-cell acute lymphoblastic leukemia
1个月前
已完结
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
1个月前
已完结
Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial
1个月前
已关闭
Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial
1个月前
已关闭
Nanobody-based naturally selected CD7-targeted CAR-T therapy for acute myeloid leukemia
1个月前
已完结
Fratricide-resistant CD7-CAR T cells in T-ALL
1个月前
已完结
Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
1个月前
已完结
皖公网安备34019202002308
